| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 20.30 | 0.03 (+0.15%) | 10.30 - 21.69 | 332.5 thousand (Below Avg) |
Market data as of 4:00PM 05/24/13. Quotes are delayed by at least 15 min.
| Open | 20.22 |
|---|---|
| Previous Close | 20.27 |
| Day's Range | 20.06 - 20.42 |
| Market Cap | 1.4B |
| Avg Volume (10 Day) | 670.3K |
| Price/Earnings (Trailing 12 Mo.) | -- |
| Earnings Per Share (Trailing 12 Mo.) | -0.74 |
| Dividend Yield | No Dividend |


These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Performed well consistently? | Fail |
|---|---|
| Avoids excess debt? | Pass |
| Converting sales to profits? | Fail |
| Shareholder's money handled rationally? | Fail |
| Increased shareholder value? | Fail |
| Consistently increased owner earnings? | Fail |
| Sells at 25% discount to intrinsic value? | Neutral |


These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Pays a cash dividend? | Fail |
|---|---|
| Room to increase dividends? | Fail |
| Increased earnings over time? | Fail |
| Borrows within reasonable limits? | Pass |
| Stock is undervalued? | Fail |
| Have investors caught on? | Fail |
| Has support of institutional investors? | Fail |
| Has sufficient liquidity? | Pass |
DexCom Announces Upcoming Presentations
Business Wire - Thursday 05/09/2013 8:30 AM ET
DexCom Inc. Reports First Quarter 2013 Financial Results
Business Wire - Wednesday 05/01/2013 4:01 PM ET
DexCom Schedules First Quarter 2013 Earnings Release and Conference Call for May 1, 2013 at 4:30 p.m. Eastern Time
Business Wire - Wednesday 04/24/2013 8:30 AM ET
| DXCM | Industry Range | |
|---|---|---|
| Revenue Growth (1yr) | 33.12% | |
| Net Income Growth (1yr) | -- | |
| Total Debt/Equity | 0.10 | |
| LT Debt/Equity | 0.09 | |
| Earnings Yield | -- | |
| Price/Sales | 13.10 |
| Company | Last | Change |
|---|---|---|
| HeartWare International Inc | 92.33 | -0.39% |
| Insulet Corp | 29.64 | +1.33% |
| Thoratec Corp | 31.39 | -0.41% |
| Conceptus Inc | 30.97 | -0.03% |
| Integra LifeSciences Holdings Corp | 36.40 | -0.30% |
Data is delayed by at least 15 min.